Respiratory Pathogens

Rapid Detection of Respiratory Pathogens

HealthTrackRx (HTRx) is the premier specialty diagnostic laboratory dedicated to the detection of infectious diseases.

With a decades-long track record of industry-leading technological advancement, our assays deliver accurate, actionable data with best-in-class turnaround time.

99% of samples received by our lab are reported out within 24-36 hours of receipt.

Eliminate the Guesswork in Diagnosis and Treatment

Our RPP pathogen assay utilizes the latest in quantitative RT-PCR technology to rapidly and reliably analyze your patient’s sample.

We rapidly detect and differentiate 99% of the most relevant bacterial, viral, and fungal targets, including Influenza, COVID-19, Haemophilus influenza, Streptococcus pneumoniae and Staphylococcus aureus.

Our molecular technique provides a more definitive diagnosis than POC antigen assays and conventional culture*

Our Respiratory Diagnostics:

  • Reduce false negatives
  • Detect polymicrobial infections
  • Are unaffected by concurrent antibiotic use
  • Include one of the most extensive antibiotic resistance gene panels
  • Reduce unnecessary drug exposure and adverse events
  • Report within 24-36 hours of sample receipt

Prescribe with Confidence

As the leader in testing sensitivity and specificity, our reports include a custom-designed accurate and detailed antibiogram.

  • Support antibiotic stewardship by reducing over-utilization of broad-spectrum anti-infectives
  • Decrease the need for empiric therapy
  • Reduce unnecessary drug exposure, adverse events, cost of repeat testing, and multiple treatment attempts

The New 99%

  • Over 99% of results are reported within 24-36 hours of sample receipt

  • Over 99% sensitivity to reduce false positives

  • Over 99% specificity to reduce false positives

  • Over 99% of the most common pathogens detected

  • 100% trackable samples and results

Respiratory Pathogens

  • Acinetobacter baumanii
  • Adenovirus HAdV-B
  • Aspergillus flavus, fumigatus, niger, terreus

  • Bordetella pertussis, parapertusis, bronchiseptica
  • Candida albicans, glabrata, parapsilosis, tropicalis
  • Candida auris

  • Chlamydia tracomatis
  • Chlamydophila pneumoniae
  • Coronavirus (229E, NL63, )C43, and HKU1)
  • COVID-19 Coronavirus (SARS-CoV-2)

  • Escherichia coli
  • Enterobacter aerogenes, cloacae
  • Enterovirus A+B+C
  • Enterovirus D
  • Haemophillus influenzae
  • Varicella zoster virus (Human Herpes Virus 3)
  • Human metapneumovirus
  • Influenza virus A,B probes
  • Klesiella 'pneumoniae', ooxytoca
  • Legionella pneumophila
  • Moraxella catarrhalis
  • Mycoplasma pneumoniae
  • Mycobacterium avium-intracellulare, kansasii
  • Neisseria gonorrhoeae
  • Parainfluenza virus (types 1, 2, 3, 4)
  • Proteus mirabilis, vulgaris
  • Pseudomonas aeruginosa
  • Respiratory syncytial virus
  • Rhinovirus A+B+C
  • Rhizopus spp, Mucor spp.
  • Serratia marcescens
  • Staphylococcus aureus
  • Staphylococcus spp
  • Streptococcus agalactiae (Group B strep (GBS))
  • Streptococcus pneumoniae
  • Steptococcus pyogenes (Group A strep)

Antibiotic Resistance Genes

  • VanA, VanB (Vancomycin resistance)
  • ermB, C; mefA (Macrolide Lincosamide Streptogramin)
  • SHV, KPC Groups (Class A beta lactamase)
  • dfr (A1, A5), sul (1, 2) probes (Trimethoprim/Sulfamethoxazole resistance)
  • mecA (Methicillin gene)
  • qnrA1, qnrA2, qnrB2 (Fluoroquinolone genes)
  • tet B, tet M (Tetracycline genes)
  • IMP, NDM, VIM Groups (Class B metallo beta lactamase)
  • ACT, MIR, FOX, ACC Groups (AmpC beta lactamase)
  • OXA-48,-51 (Class D oxacillinase)
  • CTX-M1 (15), M2 (2), M9 (9), M8/25 Groups (Class A beta lactamase)

*Rhoads, D., Wolcott, R., Sun, Y., Dowd, S. (23 February 2012). Comparison of culture and molecular identification of bacteria in chronic wounds. Int. J. Mol. Sci., 13, 2535-2550. Retrieved from www.mdpi.com/journal.ijms

Learn More

Ready to improve outcomes with fast, accurate diagnostic results? Contact us to learn more.

Click below to schedule your consultation.

Schedule A Consultation